Article ID Journal Published Year Pages File Type
8791860 Experimental Eye Research 2018 24 Pages PDF
Abstract
Our initial findings showed that when treated with bevacizumab and ranibizumab, both AMD cybrids and age-matched normal cybrids had a significant decrease in bead-uptake. A similar decrease in bead-uptake was found in normal cybrids treated with aflibercept and while the AMD values trended lower, they were not significant. This data suggests that anti-VEGF drugs can cause loss of phagocytic function.
Related Topics
Life Sciences Immunology and Microbiology Immunology and Microbiology (General)
Authors
, , , , ,